ArriVent BioPharma
AVBP
#7246
Rank
C$0.78 B
Marketcap
C$15.09
Share price
-6.57%
Change (1 day)
-47.42%
Change (1 year)

ArriVent BioPharma (AVBP) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : C$39.97 Million

According to ArriVent BioPharma's latest financial reports the company's total liabilities are C$39.97 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

ArriVent BioPharma - Total liabilities on balance sheet (from 2022 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$35.53 M43.22%
2024-12-31C$24.8 M-94.09%
2023-12-31C$0.41 B15.38%
2022-12-31C$0.36 B15592.47%
2021-12-31C$2.31 M